Share

July 2022; 9 (4) Clinical/Scientific NoteOpen Access

βIV-Spectrin Autoantibodies in 2 Individuals With Neuropathy of Possible Paraneoplastic Origin

A Case Series

Christopher M. Bartley, Thomas T. Ngo, Bonny D. Alvarenga, Andrew F. Kung, Lindsay H. Teliska, Michael Sy, Joseph L. DeRisi, Matthew N. Rasband, Sean J. Pittock, Divyanshu Dubey, Michael R. Wilson, Samuel J. Pleasure
First published May 17, 2022, DOI: https://doi.org/10.1212/NXI.0000000000001188
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
255

Share

Article Information

vol. 9 no. 4 e1188
DOI: 
https://doi.org/10.1212/NXI.0000000000001188
PubMed: 
35581007
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received January 16, 2022
  • Accepted in final form April 18, 2022
  • First Published May 17, 2022.
Copyright & Usage: 
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Christopher M. Bartley, MD* (christopher.bartley{at}ucsf.edu),
    2. Thomas T. Ngo, BS* (thomas.ngo{at}ucsf.edu),
    3. Bonny D. Alvarenga, BA (bonny.alvarenga{at}ucsf.edu),
    4. Andrew F. Kung, BA (andrew.kung{at}ucsf.edu),
    5. Lindsay H. Teliska, BS (lindsay.teliska{at}bcm.edu),
    6. Michael Sy, MD (msy{at}hs.uci.edu),
    7. Joseph L. DeRisi, PhD (joseph.derisi{at}ucsf.edu),
    8. Matthew N. Rasband, PhD (rasband{at}bcm.edu),
    9. Sean J. Pittock, MD (pittock.sean{at}mayo.edu),
    10. Divyanshu Dubey, MBBS (dubey.divyanshu{at}mayo.edu),
    11. Michael R. Wilson, MD, MAS (michael.wilson{at}ucsf.edu) and
    12. Samuel J. Pleasure, MD, PhD
  1. Christopher M. Bartley, MD* (christopher.bartley{at}ucsf.edu),
  2. Thomas T. Ngo, BS* (thomas.ngo{at}ucsf.edu),
  3. Bonny D. Alvarenga, BA (bonny.alvarenga{at}ucsf.edu),
  4. Andrew F. Kung, BA (andrew.kung{at}ucsf.edu),
  5. Lindsay H. Teliska, BS (lindsay.teliska{at}bcm.edu),
  6. Michael Sy, MD (msy{at}hs.uci.edu),
  7. Joseph L. DeRisi, PhD (joseph.derisi{at}ucsf.edu),
  8. Matthew N. Rasband, PhD (rasband{at}bcm.edu),
  9. Sean J. Pittock, MD (pittock.sean{at}mayo.edu),
  10. Divyanshu Dubey, MBBS (dubey.divyanshu{at}mayo.edu),
  11. Michael R. Wilson, MD, MAS (michael.wilson{at}ucsf.edu) and
  12. Samuel J. Pleasure, MD, PhD
  1. From the Weill Institute for Neurosciences (C.M.B., T.T.N., B.D.A., M.R.W., S.J. Pleasure), Department of Psychiatry and Behavioral Sciences (C.M.B., T.T.N.), Department of Neurology (B.D.A., M.R.W., S.J. Pleasure), UCSF School of Medicine (A.F.K.), University of California, San Francisco; Department of Neuroscience (L.H.T., M.N.R.), Baylor College of Medicine, Houston, TX; Department of Neurology (M.S.), University of California, Irvine; Chan Zuckerberg Biohub (J.L.D.), San Francisco, CA; Department of Biochemistry and Biophysics (J.L.D.), University of California, San Francisco; Department of Laboratory Medicine and Pathology (S.J. Pittock, D.D.), Department of Neurology (S.J. Pittock, D.D.), andCenter MS and Autoimmune Neurology (S.J. Pittock, D.D.), Mayo Clinic, Rochester, MN.
  1. Correspondence
    Dr. Pleasure samuel.pleasure{at}ucsf.edu
View Full Text

Article usage

Article usage: May 2022 to July 2022

AbstractFullPdfSource
May 20225488114Highwire
Jun 2022321588Highwire
Jul 2022415953Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Advertisement